James Patrick Kelly - Dec 31, 2024 Form 4 Insider Report for NOVAVAX INC (NVAX)

Role
EVP, CFO and Treasurer
Signature
/s/Mark J. Casey, Attorney-in-Fact
Stock symbol
NVAX
Transactions as of
Dec 31, 2024
Transactions value $
-$135,924
Form type
4
Date filed
1/3/2025, 05:41 PM
Previous filing
Aug 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVAX Common Stock Options Exercise $0 +35K +241.25% $0.00 49.5K Dec 31, 2024 Direct
transaction NVAX Common Stock Tax liability -$136K -16.9K -34.15% $8.04 32.6K Dec 31, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVAX Restricted Stock Units Options Exercise $0 -35K -100% $0.00 0 Dec 31, 2024 Common Stock 35K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vest with respect to one-half (1/2) of the RSUs on each of the first two (2) anniversaries of the grant date, in each case subject to continued employment with the Company through such vesting date.